DEFECT OF A COMPLEMENT RECEPTOR-3 EPITOPE IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:22
作者
WITTE, T
DUMOULIN, FL
GESSNER, JE
SCHUBERT, J
GOTZE, O
NEUMANN, C
TODD, RF
DEICHER, H
SCHMIDT, RE
机构
[1] HANNOVER MED SCH, ZENTRUM INNERE MED & DERMATOL, KLIN IMMUNOL & DERMATOL ABT, POSTFACH 616180, W-3000 HANNOVER 61, GERMANY
[2] UNIV GOTTINGEN, ZENTRUM HYG & HUMAN GENET, IMMUNOL ABT, W-3400 GOTTINGEN, GERMANY
[3] UNIV MICHIGAN, SIMPSON MEM RES INST, DIV HEMATOL & ONCOL, ANN ARBOR, MI 48109 USA
关键词
COMPLEMENT RECEPTOR 3; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; IMMUNE COMPLEXES; CLEARANCE;
D O I
10.1172/JCI116688
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Complement receptor 3 (CR3) is expressed on cells of the reticuloendothelial system and involved in the clearance of immune complexes. In this article a patient with a deficiency of the C3bi binding site of this receptor is described. Clinically this patient exhibited predominantly cutaneous manifestations of a systemic lupus erythematosus with an immune vasculitis and panniculitis. The deficiency of the CR3 epitope was demonstrated using flow cytometry. The functional relevance of this defect was demonstrated in a rosetting assay with C3bi-loaded erythrocytes. C3bi binding was found to be significantly decreased. Furthermore, there was an impairment of phagocytosis of opsonized Escherichia coli. The CR3 defect is not due to an autoantibody but is assumed to have a genetic basis. These data suggest that the defect of the CR3 may be involved in the pathogenesis of the immune vasculitis in this patient.
引用
收藏
页码:1181 / 1187
页数:7
相关论文
共 42 条
[1]   AUTOANTIBODY-MEDIATED ACQUIRED DEFICIENCY OF C1 INHIBITOR [J].
ALSENZ, J ;
BORK, K ;
LOOS, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (22) :1360-1366
[2]   DEFICIENCY OF A GRANULOCYTE-MEMBRANE GLYCOPROTEIN (GP150) IN A BOY WITH RECURRENT BACTERIAL-INFECTIONS [J].
ARNAOUT, MA ;
PITT, J ;
COHEN, HJ ;
MELAMED, J ;
ROSEN, FS ;
COLTEN, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (12) :693-699
[3]   COMPLEMENT DEFICIENCY - PREDISPOSING FACTOR TO AUTOIMMUNE SYNDROMES [J].
ATKINSON, JP .
AMERICAN JOURNAL OF MEDICINE, 1988, 85 (6A) :45-47
[4]   FILM DETECTION METHOD FOR TRITIUM-LABELED PROTEINS AND NUCLEIC-ACIDS IN POLYACRYLAMIDE GELS [J].
BONNER, WM ;
LASKEY, RA .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1974, 46 (01) :83-88
[5]   AUTOIMMUNE MICE MAKE ANTI-FC-GAMMA RECEPTOR ANTIBODIES [J].
BOROS, P ;
CHEN, JM ;
BONA, C ;
UNKELESS, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (05) :1581-1595
[6]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[7]   MECHANISM OF INHIBITION OF IMMUNOGLOBULIN G-MEDIATED PHAGOCYTOSIS BY MONOCLONAL-ANTIBODIES THAT RECOGNIZE THE MAC-1 ANTIGEN [J].
BROWN, EJ ;
BOHNSACK, JF ;
GRESHAM, HD .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :365-375
[8]   AN ABNORMALITY OF THE GENE THAT ENCODES NEUTROPHIL FC-RECEPTOR-III IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
CLARK, MR ;
LIU, L ;
CLARKSON, SB ;
ORY, PA ;
GOLDSTEIN, IM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :341-346
[9]   THE MOLECULAR-BASIS FOR GENETIC DEFICIENCY OF THE 2ND COMPONENT OF HUMAN-COMPLEMENT [J].
COLE, FS ;
WHITEHEAD, AS ;
AUERBACH, HS ;
LINT, T ;
ZEITZ, HJ ;
KILBRIDGE, P ;
COLTEN, HR .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (01) :11-16
[10]  
CORBI AL, 1988, J BIOL CHEM, V263, P12403